Dr. Pendergrass is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7901 E 22nd St
Tucson, AZ 85710Phone+1 520-694-8888Fax+1 520-694-8424
Summary
- Dr. Merri Pendergrass is an endocrinologist in Tucson, AZ and is affiliated with multiple hospitals in the area, including Banner - University Medical Center South and Banner University Medical Center-Tucson. She received her medical degree from University of Texas Southwestern Medical School and has been in practice 28 years. She specializes in diabetes and lipid metabolism.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 1992 - 1995- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1989 - 1992
University of Texas Southwestern Medical SchoolClass of 1989
Certifications & Licensure
AZ State Medical License 2012 - 2025
TX State Medical License 1990 - 2024
MA State Medical License 2003 - 2012
LA State Medical License 1997 - 2010- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2002
Publications & Presentations
PubMed
- 793 citationsInsulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.Kenneth Cusi, Katsumi Maezono, Abdullah A. Osman, Merri Pendergrass, Mary-Elizabeth Patti
The Journal of Clinical Investigation. 2000-02-01 - 70 citationsEffects of a computerized order set on the inpatient management of hyperglycemia: a cluster-randomized controlled trial.Jeffrey L. Schnipper, Catherine Liang, Chima D. Ndumele, Merri Pendergrass
Endocrine Practice. 2010-03-01 - 43 citationsExenatide and sitagliptin are not associated with increased risk of acute renal failure: a retrospective claims analysis.Merri Pendergrass, Cynthia Fenton, Steven M. Haffner, W. Chen
Diabetes, Obesity & Metabolism. 2012-07-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
